Lemaitre Vascular (LMAT) Gross Profit (2010 - 2026)

Lemaitre Vascular (LMAT) has reported Gross Profit for 17 consecutive years, with $50.8 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, Gross Profit rose 12.87% year-over-year to $50.8 million in Q2 2026; TTM through Jun 2026 was $191.3 million, a 17.97% increase from a year earlier, with the FY2025 full-year figure at $178.5 million, up 18.32% from the prior year.
• Gross Profit was $50.8 million for Q2 2026 at Lemaitre Vascular, up from $48.4 million in the prior quarter.
• Over five years, Gross Profit peaked at $50.8 million in Q2 2026 and troughed at $25.1 million in Q3 2022.
• A 5-year average of $36.7 million and a median of $36.9 million in 2024 frame the typical range for Gross Profit.
• Across the five-year window, Gross Profit grew 0.38% in 2022 and gained 27.68% in 2023, its largest moves.
• Over 5 years, Gross Profit stood at $26.1 million in 2022, then grew by 27.68% to $33.3 million in 2023, then rose by 16.01% to $38.6 million in 2024, then advanced by 19.69% to $46.2 million in 2025, then advanced by 9.9% to $50.8 million in 2026.
• The last three Gross Profit figures came in at $50.8 million (Q2 2026), $48.4 million (Q1 2026), and $46.2 million (Q4 2025), per Business Quant data.